Meet Resmonics co-founder Peter Tinschert and find out how he makes disease monitoring more convenient

18.05.2021 09:00, Isabelle Mitchell

Peter Tinschert co-founded Resmonics, a Venture Leader Mobile that develops respiratory disease monitoring using clinically validated biomarkers. Resmonics’ first product, ResGuard Med, uses patients’ smartphones to automatically and passively monitor symptoms at night and warn patients of potentially life-threatening disease exacerbations, such as asthma attacks. Learn more about Peter’s expectations for the Venture Leaders Mobile experience and discover what his dog has to do with productivity.

The Venture Leaders Mobile 2021 will accelerate their expansion into the global market and strengthen their business network by attending the Mobile World Congress 2021 in Barcelona, Spain, to meet with top-notch investors and industry leaders. To introduce you to the members of the Swiss National Startup Team, we asked each entrepreneur to complete a short profile and choose six questions from a questionnaire about their personal and professional life.

Name: Peter Tinschert 
Location: Zurich
Nationality: German
Graduated from: University of St. Gallen, PhD in Management, 2020   
Job title: Co-founder and CEO of Resmonics
Number of employees: 7 
Money raised: Undisclosed investment in pre-Seed round 
First touchpoint with Venturelab: In January 2020, at an intro event to Venture Kick  
 
“Resmonics turns the smartphone into a guardian angel at night by helping patients with respiratory diseases to spot life-threatening deteriorations earlier.” 
 
How and where did you come up with the idea for your startup?  
In the first month of my PhD in early 2016, I’ve looked into the clinical literature on asthma and found that regularly keeping track of symptoms is important for good clinical outcomes, but many patients are not doing so because today’s methods are not convenient enough. Understandably, patients don’t enjoy filling out symptom diaries daily.  
Around the same time, I’ve learned about the great technological possibilities that AI and mobile sensing offered. Connecting both dots—using AI on the smartphone to monitor asthma symptoms conveniently—laid the foundation for Resmonics.  
 
What do you expect from the Venture Leaders roadshow, and how will it help you achieve your vision?
We will release our first product, ResGuard Med, this month. Venture Leaders is the ideal roadshow to boost our entry into the European market: We will learn from like-minded entrepreneurs and meet investors with a strong track record in mobile technology. The cherry on top: We can promote our product and establish partnerships with startups and companies at the Mobile World Congress. Our vision is to bring our solution into the hands of patients worldwide, and the Venture Leaders program will help us achieve this vision by enabling a successful market entry in Europe. 
 
What is one thing not many people know about you?  
People who get to know me are often quite surprised when they find out that I’ve initially studied psychology. Many people don’t realize that statistics and clinical research are a large part of a psychology degree, so founding a startup focusing on data science in respiratory diseases is not as odd as it may seem for somebody who studied psychology. 
 
What is the one talent you wish you had? 
I would love to be able to write important emails more quickly. I am amazed at people who can write and send emails to important customers or stakeholders in just a few minutes without having to re-read them 10 times.
 
What is your favorite podcast?  
Making Sense by Sam Harris. It offers nuanced conversations with thought leaders from many different fields, sometimes also on controversial topics. I can recommend it to anyone who enjoys fact-based conversations. 
 
What is your favorite productivity hack?  
It’s a bit counterintuitive, but my number-one productivity hack during the pandemic was owning a dog. The daily dose of physical activity and distraction from the monotonous home office life helped me stay mentally engaged and motivated. Come to think of it, I probably had my best ideas in the last year when I was walking my dog.  
 
What is the most challenging aspect of being a founder? 
It’s the constant ups and downs. It’s sometimes hard to celebrate successes if you know that the next setback is lurking just around the corner. But on the flip side, it never gets boring! 
 
What is the most important lesson you have learned as a founder?  
Technologies and business models can and will change along the way, but there is no remedy for a team that does not work well together. The importance of a well-functioning team cannot be overstated for an early-stage startup. 

Last but not least, could you show us your workspace? 
Resmonics co-founders Dr. Iris Shih (CTO) and Dr. Peter Tinschert (CEO)


For more information and updates on Resmonics and the Venture Leaders Mobile, follow the Venture Leaders Mobile 2021 team with #VleadersMobile on social media or subscribe to our newsletter. 
 
This year's Venture Leaders Mobile program is supported by Huawei, Swisscom, and VISCHER.